UPM Raflatac launches non-migration adhesive for pharma market

UPM Raflatac has launched its RP 31 Purus non-migration adhesive aimed at the pharmaceutical market. Whenever labels are applied to liquid-filled low-density polyethylene (LDPE) containers, there’s a risk of adhesive migration and a need for a non-migration adhesive. UPM Raflatac’s new product satisfies this requirement.

RP 31 Purus is said to be suitable for demanding pharmaceutical applications and to provide excellent functionality on small diameters. It performs equally well on a range of substrates – from PP, PE and glass to LDPE. LDPE is used particularly for squeezable nose and eye drop containers, where a non-migration adhesive is vital.

An environmentally friendly APEO-free (alkyl phenol ethoxylate) formulation makes RP 31 Purus compliant to EU Directive 2003/53/EC. Long-term raw material component supply has been secured to provide the stability required in the pharmaceutical market.

RP 31 Purus is supplied with a full range of pharmaceutically proven face materials to cover a broad spectrum of end-uses. The adhesive is suitable for sterilization by autoclave, ETO and gamma radiation. Detailed support documentation, including a migration study and validation support package, is available to pharmaceutical companies upon request to help them proceed with their homologation processes.

Click here for more stories about UPM Raflatac on L&L.com.